Results 61 to 70 of about 1,373,606 (217)

Dynamic Prognostic Value of IL‐6/PLT Ratio for Mortality Discrimination in Patients With Crimean‐Congo Hemorrhagic Fever: Sequential ROC Analysis Throughout the Clinical Course

open access: yesJournal of Medical Virology, Volume 98, Issue 8, August 2026.
ABSTRACT This study aimed to compare the prognostic performances of individual laboratory parameters and biomarker ratios derived from them formortality in patients with Crimean‐Congo Hemorrhagic Fever (CCHF), and to examine the temporal stability of the strongest index.
Murtaza Öz   +9 more
wiley   +1 more source

Clinical and pathologic features of Crimean-Congo hemorrhagic fever

open access: yes, 2007
This chapter describes the story of the clinical process starting from the entrance of the virus to the human body to the death, if happens. Humans are the only known host of Crimean-Congo hemorrhagic fever virus (CCHFV) in which disease is manifested ...

core   +1 more source

Bayesian Phylogeography of Crimean-Congo Hemorrhagic Fever Virus in Europe

open access: yesPLoS ONE, 2013
Crimean-Congo hemorrhagic fever (CCHF) is a zoonosis mainly transmitted by ticks that causes severe hemorrhagic fever and has a mortality rate of 5-60%. The first outbreak of CCHF occurred in the Crimean peninsula in 1944-45 and it has recently emerged in the Balkans and eastern Mediterranean.
G. Zehender   +11 more
openaire   +6 more sources

Crimean-Congo Hemorrhagic Fever Virus, Mongolia, 2013–2014 [PDF]

open access: yesEmerging Infectious Diseases, 2018
During 2013-2014, we collected 1,926 serum samples from humans and 4,583 ticks (Hyalomma asiaticum or Dermacentor nuttalli) in select regions of Mongolia to determine the risk for Crimean-Congo hemorrhagic fever virus (CCHFV) infection among humans in this country.
Matthew A. Voorhees   +10 more
openaire   +3 more sources

Vectors and Vector‐Borne Diseases: Biology, Epidemiology and Integrated Control Strategies

open access: yesJournal of Applied Entomology, Volume 150, Issue 7, Page 990-1015, August 2026.
ABSTRACT Vector‐Borne Diseases (VBDs), transmitted by arthropods such as mosquitoes, ticks, fleas and sandflies, represent a significant threat to global health. These diseases can be caused by a variety of pathogens, including bacteria, viruses, protozoa, and helminths.
Roberta Rinaldi   +4 more
wiley   +1 more source

A case of brucellosis mimicking Crimean-Congo hemorrhagic fever

open access: yesJournal of Infection and Public Health, 2015
Summary: Brucellosis is a zoonotic disease caused by Brucella spp. that is transmitted to humans by the ingestion of unpasteurized milk and other dairy products from infected animals or through close contact with secretions.
Ozge Metin   +6 more
doaj   +1 more source

Crimean‐Congo Haemorrhagic Fever Virus Exposure in Horses and Donkeys in Border Livestock Markets of Nigeria

open access: yesZoonoses and Public Health, Volume 73, Issue 5, Page 422-430, August 2026.
ABSTRACT Introduction Crimean‐Congo haemorrhagic fever virus (CCHFV) is a tick‐borne zoonotic pathogen of major public health importance in Africa. Although CCHFV exposure has been reported in several livestock species in Nigeria, data on equids remain limited despite their extensive involvement in livestock movement and trade.
David O. Ehizibolo   +14 more
wiley   +1 more source

The Impact of Admission Viral Load and Inflammatory Markers on Mortality and Prognosis in Crimean‐Congo Hemorrhagic Fever

open access: yesJournal of Medical Virology, Volume 98, Issue 7, July 2026.
ABSTRACT This study aimed to evaluate the impact of admission viral load and biochemical parameters on mortality and disease severity in a large cohort of patients with Crimean‐Congo Hemorrhagic Fever (CCHF). This retrospective cohort study included 492 adult patients diagnosed with CCHF between 2022 and 2025.
Yasemin Çakır Kıymaz   +4 more
wiley   +1 more source

Optimal Dose and Safety of Intravenous Favipiravir in Hospitalized Patients With COVID‐19: A Dose‐Escalating, Randomized Controlled Phase Ib Study

open access: yesClinical Pharmacology &Therapeutics, Volume 119, Issue 6, Page 1650-1661, June 2026.
AGILE (NCT04746183) is a Phase Ib/IIa platform, evaluating candidates to treat COVID‐19. Candidate Specific Trial 6 evaluated the safety and optimal dose of a novel intravenous formulation of favipiravir in a dose‐escalating, open‐label, randomized, controlled, Bayesian adaptive Phase Ib trial.
Tim Rowland   +48 more
wiley   +1 more source

Genetic Analysis of Crimean-Congo Hemorrhagic Fever Virus in Russia [PDF]

open access: yesJournal of Clinical Microbiology, 2003
ABSTRACT Genetic analysis of wild-type Crimean-Congo hemorrhagic fever (CCHF) virus strains recovered in the European part of Russia was performed. Reverse transcriptase PCR followed by direct sequencing was used to recover partial sequences of the CCHF virus medium (M) genome segment (M segment) from four pools of ...
Lyudmila, Yashina   +11 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy